Grant Awards

Overview

Product Development Grants

Company Commercialization

This award is for innovative products addressing critically important needs related to diagnosis, prevention, and/or treatment of cancer and the product development infrastructure needed to support these efforts. The long-term objective of this award is to support commercially oriented translational research, therapeutic and medical technology products, diagnostic- or treatment-oriented information technology products, diagnostics, tools, services, and infrastructure projects.

Established Company

This award mechanism seeks to fund the research and development of innovative products, services, and infrastructure with significant potential impact on patient care. Companies must have at least one round of professional institutional investment, and must be headquartered in Texas. The proposed project must further the development of new products for the diagnosis, treatment, or prevention of cancer; must establish infrastructure that is critical to the development of a robust industry; or must fill a treatment or research gap.

Company Formation

This award finances the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will assist early-stage "start-up" companies by providing the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a strong presence of Texas-based employees. In determining eligibility for this award, CPRIT will evaluate whether applicants have a significant presence in Texas or are willing to relocate to Texas.

Company Recruitment

This award is to attract and establish a product development infrastructure in Texas by: (i) Supporting the formation and establishment of new startup companies in Texas that will develop products to significantly impact cancer care, and (ii) Recruiting to Texas companies with proven management teams who are focused on exceptional product opportunities to improve cancer care. These existing companies must presently be domiciled outside Texas and must be willing to relocate to and remain in Texas for a specified period upon funding.

Company Relocation

This award goal of the Company Relocation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships that are willing to relocate to Texas with the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a strong presence of Texas-based employees.

Texas Life Sciences Incubator Infrastructure Award Slate

This award developments or enhances incubator organizations that will provide valuable programs and services in Texas to enhance the ability to commercialize innovative, new products for the diagnosis, treatment, or prevention of cancer and to establish infrastructure that is critical to the development of a robust life sciences industry in the State. This award is intended to support incubator organizations located in the State (with Texas-based employees) providing incubator services to Texas-based translational research projects and startup companies.

Research Grants

Bridging the Gap: Early Translational Research Awards

Supports projects that "bridge the gap" between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario.

High Impact/High Risk Grant Awards

These grants are awarded for short-term projects that are developmental or exploratory in nature targeting new avenues of cancer research that, if successful, will contribute to major new insights into the etiology, diagnosis, treatment, or prevention of cancers.

Individual Investigator Awards

These grants are awarded for innovative research proposals directed by a single investigator addressing critically important questions that will significantly advance knowledge of the causes, preventions and/or treatment of cancer.

Multi-Investigator Awards

These awards are for integrated programs of collaborative and cross-disciplinary research among multiple investigators for projects in critical areas of cancer research that cannot be effectively addressed by an individual researcher or a group of researchers within the same discipline. The equivalent of program projects, centers, NCI SPOREs, shared instrumentation, core laboratories, clinical trials, or other types of collaborative interaction is appropriate. The maximum performance period is 5 years, with no set maximum award amount.

Multi-Investigator Research Award Continuation Grants for Years 4 and 5

These awards are for eligible organizations to continue the Multi-Investigator Research Award (MIRA) Continuation Grants for Years 4 and 5 to support integrated programs of collaborative and cross-disciplinary research among multiple investigators and focus on critical research areas that contribute meaningfully to advancing knowledge of the causes, prevention, and/or treatment of cancer. This award mechanism is open only to programs funded in 2010 pursuant to RFA R-10-MIRA1.

Planning Grant Awards (for Multi-Investigator RFAs)

These small planning grants ($25,000 or less) are awarded to assist applicants for the Multi-Investigational Research Award to coordinate activities among several institutions submitting comprehensive applications. Generally, expenses covered by the planning grant involve travel and collaboration efforts.

Shared Instrumentation Awards

This award seeks to support the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of scientifically meritorious cancer research projects.

Core Facility Support Awards

This award seeks to support the establishment or enhancement of core research facilities (laboratory based or clinical) that will provide valuable services to enhance the outcomes of scientifically meritorious cancer research projects.

Recruitment Grant Awards – CPRIT Scholar in Cancer Research

This award is for the recruitment of investigators with the ability to make outstanding contributions to the field of cancer research, promote inquiry into new areas, foster collaboration, and stimulate growth in the field.

Research Training Awards

These awards are to (1) attract outstanding predoctoral (Ph.D. or M.D./Ph.D.) and postdoctoral candidates committed to pursuing a career in basic or translational cancer research, (2) expand the skills and expertise of candidates to promote the next generation of investigators and leaders in cancer research, (3) position trainees for independent research careers, and (4) support the development of high-quality, innovative, and creative research. Awards will be considered for institutional programs, not individual fellowships.

Research Training Award Continuation Grants for Years 4 and 5

These awards are for eligible organizations to continue the integrated institutional Research Training Awards (RTA) for Years 4 and 5 to support promising individuals who seek specialized training in the area of cancer research. This award mechanism is open only to programs funded in 2010 pursuant to RFA R-10-RTA1.

Prevention Grants

Evidence-Based Prevention Programs and Services

These grants are awarded for short-term projects that propose services aimed toward prevention and reduction of the risk of cancer, early detection, and improved quality of life for survivors. Maximum award of up to $1 million for up to 24 months.

Competitive Continuation/Expansion

This mechanism is intended to fund the continuation or expansion of currently or previously funded projects that have demonstrated exemplary success as evidenced by progress reports and project evaluations.

Health Care Professional Education and Training

These awards are for providing health care professional education and training to increase the number of people who improve their health behaviors related to prevention of cancer, obtain recommended cancer screening tests, have cancers detected at earlier stages, and improve quality of life for cancer survivors.

Health Promotion, Education and Training for Public Health Care Professional Audiences

These grants solicit grant applications from qualified organizations located in the State of Texas that propose health care professional education and training and/or health promotion, education, and outreach for prevention, early detection, and survivorship of cancer for the public.  If successful, would improve the practice and performance of healthcare practitioners and increase the number of persons who improve their health behaviors related to the prevention of cancer, obtain recommended cancer screening tests, have cancers detected at earlier stages, and improve their quality of life if they are survivors of cancer.

Health Promotion, Public Education, and Outreach Programs

These grants are awarded for short-term projects that propose education using culturally competent and evidence-based methods that, if successful, would change personal behaviors, thereby leading to cancer prevention, risk reduction, early detection, and improved quality of life for survivors. Maximum award of up to $300,000 for up to 24 months.

Innovation Awards for Cancer Prevention Programs and Services

These awards are for projects or pilot programs that are exceptionally innovative and propose new ways to improve cancer prevention and control programs and services.

Planning Award - Community Collaborative Prevention Programs and Services for Breast, Cervical and Colorectal Cancers

These grants are awarded for short-term projects that propose development of collaborations that would address documented cancer prevention and control challenges. Maximum award of up to $15,000.

Texans Conquer Cancer Patient Support Services

These grants are awarded for short-term projects that propose support services to cancer patients and their families through proceeds from the sale of Texans Conquer Cancer specialty license plates. Maximum award of up to $3,000.

Community Collaborative Prevention Program

These awards are for organizations located in the State of Texas that would provide services through development of collaborations that address documented cancer prevention and control challenges. Priority areas include breast, cervical, and colorectal cancers.

Cancer Prevention Microgrants

These grants solicits grant applications from qualified organizations in the State of Texas that propose programs in the area of A) tobacco prevention and control or B) increasing delivery of primary preventive services for all cancers and screening services for breast, cervical and colorectal cancers.